Fludarabine-based Non-myeloablative Stem Cell Transplantation for Sickle Cell Disease with and without Renal Failure: Clinical Outcome and Pharmacokinetics

End-organ damage is common in patients with sickle cell disease (SCD) thereby limiting the use of allogeneic stem cell transplantation (SCT). We report the outcome of two adult SCD patients, one with end stage renal disease (ESRD), who underwent fludarabine-based non-myeloablative SCT from HLA-ident...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Horwitz, Mitchell E., Spasojevic, Ivan, Morris, Ashley, Telen, Marilyn, Essell, James, Gasparetto, Cristina, Sullivan, Keith, Long, Gwynn, Chute, John, Chao, Nelson, Rizzieri, David
Médium: Artigo
Jazyk:Inglês
Vydáno: 2007
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2153438/
https://ncbi.nlm.nih.gov/pubmed/18022571
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2007.08.050
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky